You if you want to be more specialized, there is the Beijing Chest Hospital and so on.
Beijing Chest Tumor and Tuberculosis Hospital is located at the east exit of Jingtong Expressway, the source of the world-famous Grand Canal, founded in 1955, formerly known as the Central Tuberculosis Research Institute, is now the Beijing Municipal Research Institute of Tuberculosis and Thoracic Tumor-Beijing Chest Tumor and Tuberculosis Hospital, which mainly engages in the clinical, scientific research, teaching and prevention and treatment of tuberculosis, thoracic tumors and respiratory diseases. It is a nationally renowned tertiary-level A-class designated hospital for the coordination of major diseases. It is a nationally renowned tertiary-level A-class designated hospital for the coordination of major diseases. It is also equipped with the Beijing Lung Cancer Diagnosis and Treatment Center, the National Clinical Research Base for Drugs, the Clinical Center for Tuberculosis Prevention and Control of the Chinese Center for Disease Control and Prevention, and the Consultation Center for Thoracic Tumor of the China Cancer Research Foundation.
The hospital has 533 beds with more than 30 departments of clinical, medical technology and scientific research, and the research of tuberculosis and lung cancer are the key disciplines of Beijing, and it has set up a high-tech laboratory of Beijing - Beijing Tumor Molecular Biology Laboratory Lung Cancer Sub-department. It has a full set of equipments for examination and treatment of thoracic tumor and tuberculosis, spiral CT, ECT scanner, CR digital imaging system, electronic linear gas pedal, electronic fiberoptic bronchoscope, new type of lung function instrument, color ultrasonic instrument, hyperbaric oxygen chamber, anesthesia monitoring system, exercise cardiopulmonary function instrument, automatic biochemistry instrument, brachytherapy machine, high-pressure liquid chromatography, semi-automatic bacterial detector, bacterial rapid detector and so on. Large-scale advanced medical equipment.
Over the past fifty years, a number of prestigious old experts have gathered here, including He Mu, Fan Bingzhe, Qiu Zuyuan, Yan Biya; domestic and foreign well-known thoracic surgery experts Zhao Zhiwen, Li Shiye, tuberculosis chest tumor specialists Ma Yu, Zhu Lizhen, tuberculosis prevention and treatment experts Duanmu Hongzhuan, endoscopic diagnostic examination experts Fu Yu, tumor chemotherapy experts Zhu Yunzhong, bone tuberculosis treatment experts Wu Qichu; in recent years, a number of new and promising experts have emerged. In recent years, a number of rising stars have emerged, such as Xu Shaofa, a young thoracic surgeon and vice president of Beijing Municipal Science and Technology New Star, and Li Qi, a researcher and outstanding young intellectual in Beijing, who are highly respected and have made brilliant achievements in the field of medicine.
The first anti-tuberculosis treatment with streptomycin 0.75G instead of 1.0G; the first development of new anti-tuberculosis drugs rifapentine, rifamycin, domestic rifapentine, frizomycin for the treatment of tuberculosis to achieve clinical results; in the country's first use of a needle two acupoints needling anesthesia for lung resection surgery; to complete China's first case and the second case of human lung transplantation to fill the gaps in China; the first implementation of resection of lung cancer at the same time. Earlier in China, the surgical method of radical treatment of lung cancer, which requires extensive lymph node dissection at the same time of lung cancer resection, was implemented, which standardized the surgical method of lung cancer and standardized the comprehensive treatment; the first in China to design and clinically use the new technology of esophagogastroesophageal intrabedial anastomosis in the radical esophageal cancer surgery; the first in China to carry out the research on the treatment of primary bronchopulmonary carcinoma by bronchoplasty, with the five-year survival rate reaching 38.5%, which is at the domestic advanced level and close to the international level. In China, the research on bronchoplasty and pulmonary arterioplasty for treating primary bronchial lung cancer was firstly carried out, and the five-year survival rate reached 38.5%, reaching the advanced level in China and close to the international level; the treatment effect of small-cell lung cancer was significantly improved by the method of combining chemotherapy and radiotherapy with surgery; the treatment effect of small-cell lung cancer was improved by adopting the comprehensive treatment, especially for the patients who had already lost the chance of surgery; and the treatment effect of patients with advanced stage of tumor was improved by adopting the method of integrated treatment. The five-year survival rate of small-cell lung cancer integrated treatment reaches 30%.
Up to now, the hospital has completed nearly 8000 cases of lung cancer surgery, and the comprehensive treatment of chemotherapy, radiotherapy and surgery for lung cancer has reached the domestic first-class level, and the clinical treatment of tuberculosis has reached the international advanced level.